Comparison of Amitriptyline and US Food and Drug Administration–Approved Treatments for Fibromyalgia-Reference-Cited by-同舟云学术

Comparison of Amitriptyline and US Food and Drug Administration–Approved Treatments for Fibromyalgia

Author:

Farag Hussein M.¹,Yunusa Ismaeel¹²,Goswami Hardik¹³,Sultan Ihtisham¹⁴,Doucette Joanne A.¹,Eguale Tewodros¹⁵

Affiliation:

1. Department of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston

2. Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Colombia

3. Biostatistics and Research Decision Sciences and Health Economics and Decision Sciences, Merck & Co, North Wales, Pennsylvania

4. Health Economics and Outcomes Research Neuroscience, AbbVie, Cambridge, Massachusetts

5. Department of Medicine, McGill University Health Centre, Montreal, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

Reference74 articles.

1. Fibromyalgia.;Häuser;Nat Rev Dis Primers,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology, Psychiatric Co-morbidity, and Treatment of Pain;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025